Clifford Chance advised Jacobs Holding on the deal. Jacobs Holding signed an agreement to acquire ILERNA, a leading provider of official vocational education in Spain from...
You must be a Standard 1 Year member to access this content.
Clifford Chance has acted as legal lead advisor of idealista and its shareholders, EQT, Apax and Oakley. Gianni & Origoni, Garrigues, Dentons, Clifford Chance, and A&O...
You must be a Standard 1 Year member to access this content.
On the deal, Clifford Chance advised Rivean Capital; Freshfields Bruckhaus Deringer LLP acted for First Reserve. Rivean Capital, a pioneer in European mid-market private equity, has...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised IGNIS on the deal while Uría Menéndez acted for KKR. KKR, a leading global investment firm, and IGNIS, a leading integrated global...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Glentra Capital on the deal. Glentra Capital acquired DVP Solar Worldwide from Everwood Fund V. DVP develops utility-scale solar PV and BESS...
You must be a Standard 1 Year member to access this content.
Clifford Chance acted for Arjun Infrastructure Partners and for the lenders while Allen & Overy acted for Macquarie on the acquisition. A consortium made up of...
You must be a Standard 1 Year member to access this content.
Clifford Chance acted for Brookfield as anchor investor. Lanza Capital (formerly known as Firmum Capital) has raised €550m for its second fund focused on car park opportunities....
You must be a Standard 1 Year member to access this content.
Clifford Chance advises Cinven on financing for Amara NZero acquisition, including first-ever green bond issued in connection with a European LBO. Cinven, a leading international private...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Neuraxpharm on the deal. Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, announced...
You must be a Standard 1 Year member to access this content.
Clifford Chance advised Neuraxpharm, a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders on the sale of Spanish pharmaceutical...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Ardian, a world leading private investment house, on its agreement to sell ASR Wind to Naturgy. Gómez Acebo & Pombo (GA_P) has...
You must be a Standard 1 Year member to access this content.
Clifford Chance has advised Cinven on the deal. International private equity firm Cinven announced the acquisition of a majority stake in Amara NZero from ProA Capital. Amara...
You must be a Standard 1 Year member to access this content.
